Influenza Vs Rhinovirus Differences
Published on: April 9, 2025
influenza vs rhinovirus differences
  • Article reviewer photo

    Huma Shaikh

    Bachelor of Science in Biology, The Open University, UK

The fact is that the difference between influenza and a cold caused by the rhinovirus shapes a lot in one's health and recovery. How these two quite common respiratory ailments make their difference is exciting to know, and distinguish in treatment and prevention. While both viruses do share symptoms, the results on health can be very different; thus, identification is required.

This article principally aims to inform the reader clearly about the elementary differences between the flu and rhinovirus, so he/she knows how best to handle his/her health. Unlike other viruses, the main reason this article will always distinguish influenza from rhinovirus is due to their dissimilarity in characteristics, symptoms, transmission patterns, and choices of treatment.

Overview of Influenza

Influenza is a contagious respiratory infection caused by viruses from the orthomyxoviridae family. Three primary types of influenza viruses infect humans:

  1. Influenza A is known for creating seasonal epidemics as well as pandemics. It is further categorised into subtypes based on two surface proteins: hemagglutinin (HA) and neuraminidase
  2. Influenza B causes seasonal outbreaks but is less severe than Influenza A. It lacks subtypes but does have two lineages: B/Yamagata and B/Victoria
  3. Influenza C causes minor respiratory infections and is less prevalent than A and B. It does not trigger epidemics

The structure of the influenza virus includes a spherical or filamentous shape with an envelope containing HA and NA proteins, which are crucial for the virus's ability to infect host cells and spread.1

Transmission and spread

Influenza spreads mostly by respiratory droplets produced when an infected person coughs, sneezes or speaks. These droplets can enter the lips or noses of those close or be aspirated into the lungs. Furthermore, the virus can be transmitted by contacting contaminated surfaces and then touching the face, particularly the mouth, nose, or eyes. Influenza is extremely contagious, with peak transmission occurring throughout the winter months in temperate climates. The virus can spread quickly, causing seasonal epidemics marked by dramatic spikes in influenza incidence within populations.2

Symptoms and clinical presentation

The symptoms of influenza can vary from mild to severe and include:

  • High fever
  • Chills
  • Muscle aches
  • Fatigue and weakness
  • Headache
  • Dry cough
  • Sore throat
  • Runny or stuffy nose

In some cases, particularly in young children, elderly adults, and individuals with underlying health conditions, influenza can lead to severe complications such as pneumonia, bronchitis, sinus infections, and worsening of chronic medical conditions like asthma or heart disease.

Diagnosis and testing

Diagnosing influenza can be challenging due to the overlap of symptoms with other respiratory infections. Common diagnostic methods include:3

Accurate and timely diagnosis is essential for effective treatment and management, particularly during influenza season.

Treatment and management

Treatment and management: Antivirals and supportive care are used to treat influenza.4

Antiviral medications: Take oseltamivir (Tamiflu) within 48 hours after symptom onset to minimise severity and duration. Zanamivir (Relenza) is an inhaled drug that has comparable effects to oseltamivir. Baloxavir marboxil (Xofluza) is a newer antiviral that only requires one dose.

Supportive care: Proper rest and hydration are essential for healing. Over-the-counter drugs can relieve symptoms like fever, discomfort, and congestion.

Vaccination and prevention: Annual influenza vaccine is the most effective approach to prevent infection. Every year, the vaccination is updated to match the circulating strains. Practice good hygiene by hand washing frequently, concealing coughs and sneezes, and staying away from close contact.

Overview of Rhinovirus

Rhinovirus is the most common viral infectious agent in humans, primarily responsible for the common cold. It belongs to the Picornaviridae family and is classified into three species: rhinovirus A, rhinovirus B, and rhinovirus C. There are over 100 serotypes of rhinovirus, contributing to its high prevalence and ability to cause repeated infections throughout a person's life.

Rhinovirus has a small, non-enveloped, icosahedral structure with a single-stranded RNA genome. Unlike influenza viruses, rhinoviruses do not undergo significant genetic changes, which limits their variability and makes them less likely to cause severe epidemics.5

Transmission and spread

The rhinovirus is primarily spread through respiratory droplets from coughing and sneezing. Another form of transmission involves direct contact whereby, after contacting contaminated surfaces or objects like door knobs, one later exposes these contaminated hands to the face-one's nose, mouth, and eyes.

Rhinovirus infections never stop; however, they tend to elevate in the spring and fall. The virus breeds in cold temperatures, which also explains its prevalence during these seasons. The level of infection of rhinovirus is very high; therefore, it may easily spread among crowded places and areas such as schools and workplaces.

Symptoms and clinical presentation

Rhinovirus infections typically present with mild symptoms, which can include:

  • Runny or stuffy nose
  • Sore throat
  • Cough
  • Sneezing
  • Congestion
  • Mild headache
  • Low-grade fever
  • Fatigue

Symptoms usually appear 1-3 days after exposure to the virus and last about 7-10 days. Unlike influenza, rhinovirus rarely causes severe illness or complications. However, it can exacerbate asthma or lead to secondary infections like sinusitis or ear infections in susceptible individuals.

Diagnosis and testing

Diagnosis of rhinovirus is nearly always made on clinical symptoms alone; testing is not usually required because the illness is relatively mild. However, diagnostic tools include:

PCR tests: These are very sensitive tests for the detection of viral RNA. They can detect rhinovirus, but their use is generally limited to research environments and in patients who have severe symptoms of respiratory illness.6

Viral culture: In this procedure, the virus is grown in the laboratory to be identified. It consumes a lot of time and is not done routinely for diagnosis. Since rhinovirus shares symptoms with other respiratory infections, diagnosis is primarily based on eliminating more serious illnesses like influenza or bacterial infection.

Treatment and management

There are no definite antiviral remedies against rhinovirus. The treatment is primarily oriented toward alleviating symptoms and supporting the patient in the process of recovery. This involves:

Symptomatic treatment

  • Rest: The body recovers from illness through proper rest
  • Fluids: Fluid intake thins or liquefies mucus and prevents dehydration
  • Over-the-counter drugs: Pain relievers like acetaminophen and ibuprofen, decongestants, and antihistamines relieve symptoms such as headache, cold, and a runny nose

Preventive steps

  • Good hygiene practices: Washing hands frequently with soap and water; alcohol-based hand rubs; avoiding frequent touching of face would reduce the risk of infection
  • Remaining away from close contact: Keeping appropriate social distance from infected people, and disinfecting frequently touched surfaces would avoid the contraction of the virus

Comparative analysis (Influenza Vs Rhinovirus)

AspectInfluenza


Rhinovirus
Virus family

Orthomyxoviridae
Picornaviridae
Virus typesA, B, C (A and B are most common)A, B, C (A and C more common)
Genome structureSegmented single-stranded RNASingle-stranded RNA
Surface proteinsHemagglutinin (HA) and Neuraminidase (NA)Lacks HA and NA; different entry mechanisms
SymptomsHigh fever, chills, muscle aches, fatigue, headache, dry cough, sore throat, runny/stuffy nose

 Runny/stuffy nose, sore throat, cough, sneezing, congestion, mild headache, low-grade fever  
Symptom severityOften severe, can lead to complicationsGenerally mild
Duration of illnessUp to two weeks or moreTypically 7-10 days
ComplicationsPneumonia, bronchitis, worsening of chronic conditionsRare, may exacerbate asthma or lead to secondary infections like sinusitis
SeasonalityWinter months (seasonal epidemics) Year-round, peaks in spring and fall
TransmissionRespiratory droplets, contact with contaminated surfacesRespiratory droplets, contact with contaminated surfaces
Transmission speed
Rapid, potential for widespread outbreaks
Common in crowded places, typically localised outbreaks
Diagnostic methods

Rapid Influenza Diagnostic Tests (RIDTs), PCR, viral culturePrimarily clinical diagnosis, PCR (less common)
TreatmentAntivirals (oseltamivir, zanamivir, baloxavir), supportive careSupportive care (rest, fluids, OTC medications)
VaccinationAnnual flu vaccineNo vaccine available

Prevention

Vaccination, good hygiene practicesGood hygiene practices

Impact on healthcare

  
Significant strain, high hospitalisations, economic costLower strain, fewer hospitalisations, economic cost due to productivity loss
Public health campaigns

Emphasise vaccination, symptom recognition, hygienePromote hygiene practices, symptom management

Summary

Knowing how influenza differs from rhinovirus might help set expectations to take control of health. These main differences manifested in the virus structure, genetics, magnitude, and duration of the symptoms, varying trends of transmission, type of diagnosis undertaken, and mode of treatment applied. Influenza poses a higher risk to public health than the rest of the diseases due to the potential causation of serious illness and complications, and thus yearly vaccination and strictly implemented public health measures are necessary. Whereas the rhinovirus is prevalent, in most cases it causes only a mild illness, and its prevention depends on simple hygiene practices. Indeed, awareness of the public and their education also play crucial roles for both viruses to lessen their potential harm. This means that proper, informed decisions concerning health and strategies to prevent infection are necessary.

References

Share

Bibek Rana Chhetri

Masters in Science- Biomedical Sciences, University of Chester, UK

Bibek, from Nepal, is a burgeoning scholar in the field of Biomedical Sciences, currently advancing his studies with a Master’s degree at the University of Chester, UK. His academic journey began with a Bachelor’s degree in Microbiology from St. Xavier’s College, Nepal, where he first cultivated his deep-seated enthusiasm for microbiology. With a robust background as a public health content writer back home, Bibek has successfully bridged the gap between scientific inquiry and public engagement. He has contributed to diverse research projects, including original research, narrative reviews, systematic reviews, and meta-analyses, demonstrating a keen aptitude for critical scientific evaluation and data synthesis. Bibek’s commitment to the microbiological sciences continues to grow as he contributes to the scientific community and healthcare advancements.

arrow-right